|
Volumn 2012, Issue , 2012, Pages 276-283
|
Advances in stem cell transplantation and gene therapy in the β-hemoglobinopathies.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD34 ANTIGEN;
HEMOGLOBIN F;
ALLOTRANSPLANTATION;
BETA THALASSEMIA;
BIOLOGICAL MODEL;
CHROMOSOME;
CLINICAL TRIAL (TOPIC);
CYTOLOGY;
DONOR;
GENE THERAPY;
GENE VECTOR;
GENETICS;
HEMATOPOIETIC STEM CELL;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEMOGLOBINOPATHY;
HOMEOSTASIS;
HUMAN;
LENTIVIRINAE;
METABOLISM;
METHODOLOGY;
MUTAGENESIS;
MUTATION;
PHENOTYPE;
REVIEW;
SIBLING;
SICKLE CELL ANEMIA;
TREATMENT OUTCOME;
ANEMIA, SICKLE CELL;
ANTIGENS, CD34;
BETA-THALASSEMIA;
CHROMOSOMES;
CLINICAL TRIALS AS TOPIC;
FETAL HEMOGLOBIN;
GENETIC THERAPY;
GENETIC VECTORS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEMATOPOIETIC STEM CELLS;
HEMOGLOBINOPATHIES;
HOMEOSTASIS;
HUMANS;
LENTIVIRUS;
MODELS, GENETIC;
MUTAGENESIS;
MUTATION;
PHENOTYPE;
SIBLINGS;
TISSUE DONORS;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 84878668046
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation.v2012.1.276.3807841 Document Type: Review |
Times cited : (53)
|
References (0)
|